Reuters logo
BRIEF-Adaptimmune, Bellicum Pharma collaborate to evaluate next-generation T-cell therapies
December 19, 2016 / 12:42 PM / 9 months ago

BRIEF-Adaptimmune, Bellicum Pharma collaborate to evaluate next-generation T-cell therapies

Dec 19 (Reuters) - Adaptimmune Therapeutics Plc

* Adaptimmune and Bellicum Pharmaceuticals enter a strategic collaboration to evaluate next-generation T-cell therapies

* Adaptimmune Therapeutics - Based on results from preclinical proof-of-concept phase,cos expect to progress to two-target co-development,co-commercialization phase

* Adaptimmune Therapeutics - Co’s to evaluate Bellicum’s GOTCR technology with Adaptimmune’s affinity-optimized spear T-cells to create TCR product candidates Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below